Darya Chudova is the chief technology officer at Guardant Health, where she oversees the company’s technology strategy and operations. During her time at the company, Chudova served as the senior vice president where she led the technical development of Shield, Guardant360 LDT and CDx products.

Prior to Guardant Health, Chudova developed tools for clinical diagnostics and interpretation of genomic expression and sequencing data in the context of molecular cytology at Veracyte, Inc., and non-invasive prenatal testing at Illumina, Inc.

Chodova holds a Doctor of Philosophy degree from the University of California, Irvine.